Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam)

International Journal of Cancer

Volumn 84, Issue 4, 1999, Pages 437-441

  Beemsterboer, P M M ^a   Kranse, R ^b   De Koning, H J ^a   Habbema, J D F ^a   Schroder F H ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER SCREENING; CLINICAL PROTOCOL; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY;

BIOPSY; EUROPE; FALSE POSITIVE REACTIONS; HUMANS; MALE; MASS SCREENING; NETHERLANDS; PHYSICAL EXAMINATION; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 0032796676     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990820)84:4<437::AID-IJC19>3.0.CO;2-S     Document Type: Article

References (14)

1. AUVINEN, A., RIETBERGEN, J.B., DENIS, L.J., SCHRÖDER, F.H. and PROROK, P.C., Prospective evaluation plan for randomised trials of prostate cancer screening. The International Prostate Cancer Screening Trial Evaluation Group. J. med. Screen, 3, 97-104 (1996).
2. CATALONA, W.J., SMITH, D.S. and ORNSTEIN, D.K., Prostate-cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/ml and benign prostate examination. Enhancement of specificity with free PSA measurements (see comments). J. Amer. med. Ass., 277, 1452-1455 (1997).
3. DE KONING, H.J., VAN INEVELD, B.M., VAN OORTMARSSEN, G.J., DE HAES, J.C., COLLETTE, H.J., HENDRIKS, J.H. and VAN DER MAAS, P.J., Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int. J. Cancer, 49, 531-537 (1991).
4. ESSINK-BOT, M.L., DE KONING, H.J., NUS, H.G., KIRKELS, W.J., VAN DER MAAS, P.J. and SCHRÖDER, F.H., Short-term effects of population-based screening for prostate cancer on health-related quality-of-life. J. nat. Cancer Inst., 90, 925-931 (1998).
5. HOEDEMAEKER, R.F., RIETBERGEN, J.B.W., KRANSE, R., VAN DER KWAST, T.H. and SCHRÖDER, F.H., Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer. Wld. J. Urol., 15, 339-345 (1997).
6. KRANSE, R., BEEMSTERBOER, P.M.M., RIETBERGEN, J.B.W., HABBEMA, J.D.F., HUGOSSON, J. and SCHRÖDER, F.H., Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region). Prostate (1999) (in press).
7. LODDING, P., AUS, G., BERGDAHL, S., FROSING, R., LILJA, H., PIHL, C.G. and HUGOSSON, J., Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng/ml prostate-specific antigen (see comments). J. Urol., 159, 899-903 (1998).
8. MCWHORTER, W.P., HERNANDEZ, D., MEIKLE, A.W., TERREROS, D.A., SMITH, J.A., JR., SKOLNICK, M.H., CANNON-ALBRIGHT, L.A. and EYRE, H.J., A screening study of prostate cancer in high-risk families. J. Urol., 148, 826-828 (1992).
9. PARKES, C., WALD, N.J., MURPHY, P., GEORGE, L., WATT, H.C., KIRBY, R., KNEKT, P., HELZLSOUER, K.J., and TUOMILEHTO, J., Prospective observational study to assess value of prostate-specific antigen as screening test for prostate cancer (see comments). Brit. med. J., 311, 1340-1343 (1995).
10. RIETBERGEN, J.B., KRUGER, A.E., KRANSE, R. and SCHRÖDER, F.H., Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. Urology, 49, 875-880 (1997).
11. SCHRÖDER, F.H., DAMHUIS, R.A.M., KIRKELS, W.J., DE KONING, H.J., KRANSE, R., NUS, H.G.T. and BLIJENBERG, B.G., European randomized Study of Screening for Prostate Cancer, the Rotterdam pilot studies. Int. J. Cancer, 65, 145-151 (1996).
12. SCHRÖDER, F.H., DENIS, L.J., KIRKELS, W., DE KONING, H.J. and STANDAERT, B., European Randomized Study of Screening for Prostate Cancer. Progress report of Antwerp and Rotterdam pilot studies. Cancer, 76, 129-134 (1995).
13. SMITH, D.S. and CATALONA, W.J., Inter-examiner variability of digital rectal examination in detecting prostate cancer. Urology, 45, 70-74 (1995).
14. STENMAN, U.H., HAKAMA, M., KNEKT, P., AROMAA, A., TEPPO, L. and LEINONEN, J., Serum concentrations of prostate-specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer. Lancet, 344, 1594-1598 (1994).